I like your thought also......this could very well be the case. NP made it clear that CYDY wouldn't be paying for the P2 colon trial, so this may be the first step in getting cancer off the ground.
Either way, this PR is great news. Patients injected or soon to be injected being #1 and FDA approving protocol supports CYDY credibility vs. RP dragging his feet on this IND filing. I hope to get some clarity during Thursday's meeting.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.